Funds 82 Million Sale of Vanguard Bond ETF What Investors Should Know UOB Faces High Court Criticism Over Inconsistent Legal Stance on Late Mortgage Charges BPs Abrupt Chairman Removal Linked to Alleged Bullying Behavior Company Declines Comment SP 500 and Nasdaq Hit Record Closing Highs on AI Optimism Micron Joins 1 Trillion Club Singapore Gains from AI Investment Boom but Faces Chip Supply Risks MTI Warns Copa Holdings CPA Draws Mixed Street Sentiment Amid Regional Air Travel Dynamics CYTK Q1 2026 Earnings NarrowerThanExpected Loss as Aficamten NDA Awaits FDA Review SBLK Q1 2026 Earnings Strong EPS Beat Amid Dry Bulk Headwinds Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline IMCR Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Pipeline Progress DBI Q1 2026 Earnings EPS Surprise Amid Persistent Retail Challenges STC Q1 2026 Earnings Strong EPS Surprise Drives Modest Stock Uptick Core Scientific Warrants CORZW Surge Over 5 Key Levels to Watch Redwood Trust Senior Notes RWTQ Edge Lower Amid Rate Uncertainty AGNCO Preferred Shares Hold Steady Near 2553 Amid Stable Trading AMREP Corporation AXR Edges Higher as Shares Test Near Resistance Gesher Acquisition Corp II Warrants GSHRW Hold Steady at 022 Amid Low Volatility Tamil Nadu Governor Calls for Holistic Growth Model Beyond GDP for Viksit Bharat Vision iHeartMedia Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick Real Messenger Corporation RMSG Holds Near Support Amid Modest Decline ASTC Q1 2024 Earnings Continued Losses Amid Strategic Repositioning KUST Q4 2025 Earnings Deep EPS Miss Raises Concerns Amid Unreported Revenue Addus HomeCare ADUS Q1 2026 Earnings Earnings Beat Despite Soft Stock Reaction WGRX Q1 2026 Earnings Pharmaceutical Supply Chain Firm Posts WiderThanExpected Loss Shares Tumble 22 SPAI Q1 2026 Earnings EPS Misses Estimates Amid Revenue Discontinuation PBH Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Gain SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports a Surprising Profit